oa SA Pharmaceutical Journal - Atopic eczema : current therapeutic advances : clinical
Atopic eczema significantly affects the quality of life of sufferers. <br>There are good epidemiological data supporting the view that the prevalence is on the rise. The reasons for this are not clear. <br>A single treatment modality is not sufficient in controlling the disease. <br>The availability of new classes of drugs such as calcineurin inhibitors is a significant advance in the management of atopic eczema. <br>The calcineurin inhibitors can be used as first-line therapy for atopic eczema. <br>A comprehensive approach is required encompassing allergen avoidance, use of moisturisers, careful application of topical steroids and use of the recently available topical calcineurin inhibitors. <br>Most patients can be well controlled with a combination of these treatments.
Article metrics loading...